Sneha Basak

Sneha Basak

Auto-generated profile, based on publicly available information

Sneha Basak

Kojin Therapeutics

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JEJohn K. Eaton
John K. Eaton
PCPriya Chatterji
Priya Chatterji
LFLaura Furst
Laura Furst
SBSneha Basak
Sneha Basak
APAyesha M. Patel
Ayesha M. Patel
VVVasanthi S. Viswanathan
Vasanthi S. Viswanathan
Despite glutathione’s long-recognized role as a major cellular antioxidant and its central role in ferroptosis defense, inhibition of glutathione biosynthetic enzymes has received little attention as a target for the therapeutic induction of ferroptosis. Here, we report that small-molecule inhibition of glutamate–cysteine ligase (GCL), the rate-limiting enzyme of glutathione biosynthesis, selectively and potently kills cancer cells by ferroptosis. We further describe novel GCL inhibitors including KOJ-1 and KOJ-2, compounds with excellent cellular potency and pharmacological properties, representing valuable tools to study the biology of ferroptosis and glutathione.